Non-alcoholic fatty liver disease severity is modulated by transglutaminase type 2

Non-alcoholic fatty liver disease (NAFLD) is one of the most important liver diseases worldwide. Currently, no effective treatment is available, and NAFLD pathogenesis is incompletely understood. Transglutaminase type 2 (TG2) is a ubiquitous enzyme whose dysregulation is implicated in the pathogenes...

Descripción completa

Detalles Bibliográficos
Autores principales: Piacentini, Mauro, Baiocchini, Andrea, Del Nonno, Franca, Melino, Gerry, Barlev, Nickolai A., Rossin, Federica, D’Eletto, Manuela, Falasca, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833377/
https://www.ncbi.nlm.nih.gov/pubmed/29449533
http://dx.doi.org/10.1038/s41419-018-0292-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833377/
https://www.ncbi.nlm.nih.gov/pubmed/29449533
http://dx.doi.org/10.1038/s41419-018-0292-8

Ejemplares similares